lung cancer | |||||
新闻 | |||||
Gilead, Takeda Rumored to Have Sights on Iovance The company is also testing the potential of TILs in in lung cancer and several other tumor types, including cervical cancer and head and neck tumors.
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment